Approvals/TGA/ELAPRASE idursulfase-rhu concentrate for solution for IV infusion vial

Approved

STANDARD

ELAPRASE idursulfase-rhu concentrate for solution for IV infusion vial

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 52703f9d39bfb04e
Product Name: ELAPRASE idursulfase-rhu concentrate for solution for IV infusion vial
Artg Id: 129481
Artg Name: ELAPRASE idursulfase-rhu solution for IV infusion vial
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2008-02-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b41ed4531af21381c480bba60f633d45.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/38e1e16a023d95b553f18c933466f1a6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

52703f9d39bfb04e

Type

Standard